IMNM
Immunome Inc. · Healthcare · Market cap $2.0B
Insiders sold $16.0M net in the last 90 days ·5 sellers, 0 buyers· 15 of 15 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 15, 2026
Insider Buying
$2.3M
reported purchases (SEC code P)
Insider Selling
$27.5M
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Latest filing
Sep 15, 2026
Higgins Jack
Immunome Inc. (IMNM) has 31 SEC Form 4 filings (64 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Sep 15, 2026.
Inside the rolling window, 9 insiders at Immunome Inc. reported 9 open-market purchases totaling $2.3M and 21 open-market sales totaling $27.5M. The most active filer is Director Barchas Isaac with 10 filings. Insiders have net sold $18.4M over the trailing 6 months. The most recent open-market filing is a sale of 13,200 shares by Chief Scientific Officer Higgins Jack, dated Sep 11, 2026, worth $334K.
- Industry:Biotechnology
- CEO:Clay Siegall
- Employees:247
- HQ:Bothell, WA, US
- IPO:2020-10-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
Higgins JackFirst in 6 months | Chief Scientific Officer | Sale | 13,200 | $334K | Sep 15 | -25.2% | SEC ↗ |
| Director | Sale | 10,125 | $264K | Aug 12 | -36.0% | SEC ↗ | |
| Director | Sale | 62,291 | $1.6M | Aug 12 | -36.0% | SEC ↗ | |
| Director | Sale | 11,048 | $301K | Aug 12 | -36.0% | SEC ↗ | |
| Director | Sale | 20,840 | $543K | Aug 10 | -30.2% | SEC ↗ | |
| Director | Sale | 15,248 | $397K | Aug 10 | -30.2% | SEC ↗ | |
| CHIEF BUSINESS OFFICER | Sale | 90,616 | $2.3M | Aug 6 | -30.6% | SEC ↗ | |
Horn KinneyFirst filing | CHIEF BUSINESS OFFICER | Sale | 1,092 | $27K | Jul 9 | -25.9% | SEC ↗ |
| Director | Sale | 83,094 | $2.0M | Jul 7 | -26.5% | SEC ↗ | |
| Director | Sale | 16,906 | $409K | Jul 7 | -26.5% | SEC ↗ | |
| Chief Medical Officer | Sale | 55,000 | $1.2M | Jul 7 | — | SEC ↗ | |
Barchas IsaacFirst in 6 months | Director | Sale | 101,050 | $2.1M | Jul 3 | — | SEC ↗ |
Barchas IsaacFirst in 6 months | Director | Sale | 100,000 | $2.3M | Jul 3 | — | SEC ↗ |
Lechleider RobertFirst filing | Chief Medical Officer | Sale | 55,000 | $1.1M | Jun 29 | — | SEC ↗ |
| Chief Financial Officer | Sale | 60,000 | $1.1M | Jun 17 | — | SEC ↗ | |
| Director | Sale | 10,500 | $204K | Jun 9 | — | SEC ↗ | |
| Director | Purchase | 10,500 | $204K | Jun 9 | — | SEC ↗ | |
| Director | Purchase | 5,000 | $104K | May 19 | — | SEC ↗ | |
Rosett MaxFirst filing | Chief Financial Officer | Sale | 65,000 | $1.4M | Apr 3 | — | SEC ↗ |
Higgins JackFirst filing | Chief Scientific Officer | Sale | 9,438 | $204K | Apr 3 | — | SEC ↗ |
SIEGALL CLAY BFirst in 3 months | President and CEO | Purchase | 25,450 | $501K | Mar 31 | — | SEC ↗ |
WAGENHEIM PHILIPFirst filing | Director | Sale | 36,800 | $753K | Mar 23 | — | SEC ↗ |
WAGENHEIM PHILIPFirst filing | Director | Sale | 28,200 | $582K | Mar 23 | — | SEC ↗ |
| Director | Purchase | 1,000 | $22K | Mar 12 | — | SEC ↗ | |
| Director | Purchase | 1,000 | $22K | Mar 12 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does IMNM have?
Immunome Inc. (IMNM) has 31 SEC Form 4 filings (64 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Sep 15, 2026.
When was the most recent SEC Form 4 filing for IMNM?
The most recent Form 4 filing for IMNM on Tracefour is dated Sep 15, 2026.
Who is the most active insider at IMNM?
The most active SEC Form 4 filer at IMNM in the rolling window is Director Barchas Isaac, with 10 filings.
What is the net insider flow at IMNM over the last 6 months?
Over the trailing 180 days, insiders at IMNM have net sold $18.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at IMNM in the current window?
Inside the rolling window, insiders at IMNM bought $2.3M and sold $27.5M based on SEC Form 4 filings.
Can I get alerts for IMNM insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Immunome Inc. (IMNM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Immunome Inc. is in the Healthcare sector.